Cargando…
E-cadherin might be a stage-dependent modulator in aggressiveness in pancreatic cancer cells
Pancreatic ductal adenocarcinoma (PDAC) pathology is known for its uncontrollable progress due to highly invasive characteristics and refractory behavior against existing chemotherapies. The aberrant expression of CDH1 (expresses the protein E-cadherin) is associated with increased overall survival...
Autores principales: | AYDEMİR ÇOBAN, Esra, TECİMEL, Didem, KAŞIKCI, Ezgi, BAYRAK, Ömer Faruk, ŞAHİN, Fikrettin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585161/ https://www.ncbi.nlm.nih.gov/pubmed/33110361 http://dx.doi.org/10.3906/biy-1912-60 |
Ejemplares similares
-
Inhibition of Migration, Invasion and Drug Resistance of Pancreatic Adenocarcinoma Cells – Role of Snail, Slug and Twist and Small Molecule Inhibitors
por: Kaşıkcı, Ezgi, et al.
Publicado: (2020) -
Leukemia Inhibitory Factor Promotes Aggressiveness of Chordoma
por: Gulluoglu, Sukru, et al.
Publicado: (2017) -
Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma
por: Siret, Carole, et al.
Publicado: (2018) -
The investigation of diverse physiological and therapeutic impact of cellular-based products derived from human cumulus cells
por: BURUKÇU, Derya, et al.
Publicado: (2022) -
E-Cadherin: An Enigma in Pancreatic Diseases
por: Garrido, Vanessa T., et al.
Publicado: (2019)